Navitor Pharma (@NavitorPharma) header
Navitor Pharma (@NavitorPharma) profile picture

Revealing the Therapeutic Power of mTORC1

Cambridge, MA
Joined March 2014
Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)Photo by Navitor Pharma (@NavitorPharma)
How @NavitorPharma could improve the way you age gracefully https://xitter.gq/t.co/bmIdyjlbFk
Navitor Pharma retweeted
Supernus Pharmaceuticals has struck an agreement with privately held Navitor Pharmaceuticals to run a joint phase II program for Navitor's mTORC1 activator, NV-5138, in treatment-resistant depression bioworld.com/articles/434589…
Navitor Pharma retweeted
Chief Research Officer of @NavitorPharma, Eddine Saiah, discusses selective mTORC1 modulation as novel approaches to treating #diabetes, #cancer, #fibrosis, #depression and beyond. #InnovationThatMatters Read more: wxpress.wuxiapptec.com/selec…
Our #CVForum19 advisor @LaurieAHalloran will be moderating a discussion this year focused on critical hires (Chief Development Officer or Chief Medical Officer) to get programs off the ground. She'll be joined by @TEHughes2009 and #GilmoreOneill convergenceforum.com/agenda
2
2
Navitor Pharma retweeted
New drug mimics benefits of ketamine for depression https://xitter.gq/t.co/C9YNh7KHJo @YaleMed
5
2
10
Scientists @NavitorPharma used the CLS to develop a potential therapy for treatment-resistant depression. Eddine Saiah said, "We have seen positive effects in as little as 24 hours in preclinical models." Read the full story: buff.ly/2YLUHrA
3
2
Navitor Pharma retweeted
Ketamine, depression and suicide prevention-Balanced @nytimes opinion piece. Going beyond ketamine targeting the molecular mechanisms responsible for its pharmacology like mTORC1 is the focus of @NavitorPharma efforts now being evaluated in the clinic:nytimes.com/2018/11/30/opini…
1
1
3
Navitor Pharma retweeted
mTORC1 and mTORC2 crosstalk regulation of NK cell effector function. Interesting role of mTORC1 regulation of mTORC2 activity through the maintenance of IL-15 signaling-Opportunity for selective modulation(?):nature.com/articles/s41467-0…
2
9
Navitor Pharma retweeted
Strong piece for a greater focus on mental health. New rapid acting therapies for depression by companies including ⁦@NavitorPharma⁩, ⁦@JanssenGlobal⁩, ⁦@Allergan⁩ and ⁦@SageBiotech⁩ will greatly improve therapy and help patients. theguardian.com/commentisfre…
5
3
Profile @blsabatini and I did with Spectrum on how some of our work may relate to autism: Family ties: Sabatini brothers crack codes that may underlie autism spectrumnews.org/news/profil…
4
40
6
167
Navitor Pharma retweeted
Replying to @NavitorPharma
@NavitorPharma efforts on the development of a new class of rapid acting antidepressants mentioned in @statnews: statnews.com/2018/07/03/fast…
1
5
1
2
Navitor Pharma retweeted
1
3
Monther and Greg's LysoIP method for lysosomal metabolomics science.sciencemag.org/conte…
1
10
1
32
My perspective/review on discovery of mTOR and how nutrients are sensed, with personal stories and reflections pnas.org/cgi/content/long/17…
2
77
7
155
Navitor Pharma retweeted
Thanks to @CambridgeMAFire for handling the incident at 1030 Mass Ave today. Great job as usual. xitter.gq/cambridgemafire/status…
Fire companies are starting to make up lines, Ladder 1 making up the aerial. All in the process of making up. xitter.gq/CambridgeMAFire/status…
1
1
2
Navitor Pharma retweeted
We are looking for a talented Research or Sr. Research Associate at @NavitorPharma. Please refer candidates to: navitorpharma.com/pdfs/caree…
Navitor Pharma retweeted
Phase 2b mTORC1 inhibitors study in elderly patients at increased risk of respiratory tract infections initiated businesswire.com/news/home/2…
Very much looking forward to the meeting...have not been in the original Cambridge for a long time xitter.gq/BabrahamInst/status/82…
#theageingcell conference keynote talk to be given by @DMSabatini – check out the full programme & sign up now: ow.ly/1FR7307K95l
4
7
Navitor Pharma retweeted
Short term inhibition of mTORC1 with rapamycin can have significant effects on health span and lifespan in mice:elifesciences.org/content/5/…
1
2
Navitor Pharma retweeted
Replying to @endpts @johncendpts
All about modulating mTORC1. @NavitorPharma is going beyond rapamycin to optimize the benefit of this approach.
2
2